Combination of Artificial Intelligence (ENDOAID) and Mucosal Exposure Device (ENDOCUFF) to Enhance Colorectal Neoplasia Detection: a Randomized Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The investigators hypothesize that the combined use of CADe system (ENDOAID) and mucosal exposure device (Endocuff Vision®) would improve the adenoma detection rate when compared to CADe system alone.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 85
Healthy Volunteers: t
View:
• Aged 45-85 years old;
• They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or altered bowel habit;
• Written informed consent obtained.
Locations
Other Locations
Hong Kong Special Administrative Region
Prince of Wales Hospital
RECRUITING
Shatin
Contact Information
Primary
Felix Sia
felixsia@cuhk.edu.hk
26370428
Backup
Thomas Lam
thomaslam@cuhk.edu.hk
26370428
Time Frame
Start Date: 2023-03-07
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 1726
Treatments
No_intervention: ENDOAID
CADe system will be used during withdrawal phase of colonoscopy.
Experimental: ENDOAID with ENDOCUFF
CADe system and mucosal exposure device (ENDOCUFF) will be used during withdrawal phase of colonoscopy.
Related Therapeutic Areas
Sponsors
Leads: Chinese University of Hong Kong
Collaborators: University Hospital Augsburg, Changi General Hospital